Clinical Trial

Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR)

Study acronym: Ue-STAR
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated September 5, 2024 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
A researcher-initiated and conducted multicenter, randomized controlled trial aimed at evaluating the efficacy and safety of ultra-early statin therapy in the treatment of acute aneurysmal subarachnoid hemorrhage (aSAH).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-14.
Trial Details
NCT Number NCT06559072
Lead Sponsor The George Institute
Collaborators: Tianjin Medical University General Hospital
Conditions Subarachnoid Hemorrhage, Subarachnoid Hemorrhage, Aneurysmal, Aneurysmal Subarachnoid Hemorrhage, Hemorrhage, Aneurysmal Subarachnoid
Enrollment 522 participants
Start Date 2024-09-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-09-05